These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8153471)

  • 21. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
    Kaffarnik H; Schneider J; Haase W
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
    MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipid-lowering effect of a combination of clofibrate and DL-alpha-tocopherol nicotinate in unselected hyperlipemic patients].
    Gniwotta E; Herter B
    ZFA (Stuttgart); 1977 Apr; 53(10):565-8. PubMed ID: 324162
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in the lipid metabolic indices as affected by glycyrrhenate in experimental hyperlipidemia].
    Suetina IV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1982; (8):47-50. PubMed ID: 7138977
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia.
    Schapel GJ; Edwards KD
    J Pharmacol Exp Ther; 1975 Jul; 194(1):274-84. PubMed ID: 1171221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A clofibric acid derivative with hypolipemic and platelet antiaggregant action].
    Dănilă G; Nechifor M; Filip M; Păduraru I; Ifrim C; Grădinariu D; Papa V; Manolescu A; Bădescu A
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):127-32. PubMed ID: 3393745
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative antilipidemic effects of various ethyl 5-substituted benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a triton hyperlipidemic rat model.
    Witiak DT; Newman HA; Poochikian GK; Loh W; Sankarappa SK
    Lipids; 1976 May; 11(5):384-91. PubMed ID: 1271976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of a combined treatment using clofibrate and persantin persantinat on increased serum lipid levels].
    Hammerl H; Nebosis G; Pichler O; Studlar M
    Med Welt; 1973 Mar; 24(12):468-70. PubMed ID: 4700881
    [No Abstract]   [Full Text] [Related]  

  • 29. Clofibrate treatment of hyperlipidemia in chronic renal failure.
    di Giulio S; Boulu R; Drüeke T; Nicolaĭ A; Zingraff J; Crosnier J
    Clin Nephrol; 1977 Dec; 8(6):504-9. PubMed ID: 598055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypolipidemic action of simfibrate in diabetic subjects].
    Gragnoli G; Tanganelli I; Signorini AM; Kristodhullu A
    Clin Ter; 1981 Feb; 96(4):397-408. PubMed ID: 7214862
    [No Abstract]   [Full Text] [Related]  

  • 31. [The reduction of dyslipidemia and oxidative stress in experimental diabetes mellitus treated with probucol].
    Colev V; Păduraru I; Vornicu M; Bădescu M; Mocanu V; Ciocoiu M; Saramet A; Bohotin C
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(1-2):103-7. PubMed ID: 10756736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypolipidaemic aryloxyacetic acids.
    Schacht E
    Top Curr Chem; 1977; 72():99-123. PubMed ID: 339406
    [No Abstract]   [Full Text] [Related]  

  • 33. Antihyperlipidemic activity of Clitoria ternatea and Vigna mungo in rats.
    Solanki YB; Jain SM
    Pharm Biol; 2010 Aug; 48(8):915-23. PubMed ID: 20673179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
    Sterner W; Chibanguza G; Metz G
    Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug treatment of hyperlipidemia.
    Spector AA
    J Iowa Med Soc; 1972 Oct; 62(10):524-5 passim. PubMed ID: 5074337
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of 100 cases of essential atherogenic hyperlipoproteinemia].
    Rouffy J
    Sem Hop Ther; 1975 Nov; 51(9):467-71. PubMed ID: 173023
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental hypolipidemic and antiatherosclerotic activity of bisanions].
    Ryzhenkov VE; Khromov-Borisov NV; Mosina IV; Indenbom ML
    Farmakol Toksikol; 1979; 42(6):632-5. PubMed ID: 499472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Classification and treatment of hyperlipidemia: normolipemic treatments in 1972].
    Cloarec M
    Therapeutique; 1972 Dec; 48(10):653-6. PubMed ID: 4661289
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dose-effects studies with bezafibrate in patients with hypercholesterolemia and hypertriglyceridemia (author's transl)].
    Adam O; Wolfram G; Lang PD; Zöllner N
    MMW Munch Med Wochenschr; 1979 Mar; 121(9):319-22. PubMed ID: 106264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New derivatives of clofibrate and probucol. Preliminary study of their hypolipemic activity].
    de Meglio P; Ravenna F; Manzardo S; Gentili P; Riva M
    Farmaco Sci; 1985 Nov; 40(11):833-44. PubMed ID: 4085644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.